your badges 52W Range $0–$5 87% of range Analyst Rating BUY 5 analysts Price Target $10 +113% upside P/E · ROE · Net Profit Margin ·

ICU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $4.69
Market Cap (MRQ) $19M
Debt/Equity (MRQ) 0.0
52W Range $0–$5

ICU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
Jan. 5, 2026 1-for-10 Reverse
June 10, 2024 1-for-25 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ICU 5Y avg Peer Median Verdict
P/B (MRQ) 2.6 · 2.4 Undervalued

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 16.2%
Next Report Nov 11, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 12, 2026 $-0.91 $-0.98 7.1%
March 31, 2026 May 13, 2026 $-0.90 $-0.83 -8.0%
Dec. 31, 2025 $-0.80 $-1.07 25.3%
Sept. 30, 2025 $-1.30 $-1.51 14.2%
June 30, 2025 $-1.80 $-4.34 58.6%
March 31, 2025 $-4.40 $-5.25 16.2%
Dec. 31, 2024 $-9.00 $-8.99 -0.12%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
No annual filings for ICU

We don't have SEC filings for this ticker yet.

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Institutional owners (13F) 20 filers · $673K total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 20
Value held $673K
New positions 3
Exited positions 1
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
3 (-12 vs prior Q) 1 (-7 vs prior Q) 3 (+3 vs prior Q) 4 (+2 vs prior Q) +27K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
GEODE CAPITAL MANAGEMENT, LLC $182,010 49,593 27.06% Shares
VANGUARD CAPITAL MANAGEMENT LLC $121,444 33,091 18.05% Shares
UBS Group AG $115,231 31,398 17.13% Shares
VANGUARD GROUP INC $90,570 377,377 13.46% Shares
VANGUARD FIDUCIARY TRUST CO $50,250 13,692 7.47% Shares
JANE STREET GROUP, LLC $46,367 12,634 6.89% Shares
NORTHERN TRUST CORP $38,175 10,402 5.67% Shares
PNC Financial Services Group, Inc. $18,141 4,943 2.70% Shares
Tower Research Capital LLC (TRC) $4,977 1,356 0.74% Shares
BlackRock, Inc. $3,351 913 0.50% Shares
OSAIC HOLDINGS, INC. $714 195 0.11% Shares
NewEdge Advisors, LLC $647 176 0.10% Shares
Vanguard Global Advisers, LLC $606 165 0.09% Shares
TD Waterhouse Canada Inc. $106 22 0.02% Shares
SBI Securities Co., Ltd. $51 14 0.01% Shares
SOA Wealth Advisors, LLC. $22 6 0.00% Shares
BARCLAYS PLC $15 4 0.00% Shares
HighMark Wealth Management LLC $7 2 0.00% Shares
Caitong International Asset Management Co., Ltd $7 2 0.00% Shares
CWM, LLC $4 1 0.00% Shares

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
LMFAO Sponsor, LLC, LM Funding America, Inc. Nov. 7, 2022 · Initial filing M&A / sale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 19 insiders · 6 officers · 9 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Eric Schlorff Chief Executive Officer Feb. 6, 2026 A 39,852 0 0 $0
Michael Messinger Chief Financial Officer Dec. 9, 2025 P 17,500 1 0 $5,075
David A Green Chief Financial Officer April 1, 2025 A 10,323 0 0 $0
Caryl Baron Interim CFO Nov. 29, 2023 A 139,872 0 0 $0
Kevin Chung Chief Medical Officer Feb. 6, 2026 A 20,819 0 0 $0
Bradford K Towne Principal Accounting Officer Feb. 6, 2026 A 9,050 0 0 $0
Bernadette N Vincent Director Feb. 6, 2026 A 4,200 0 0 $0
Jennifer A Baird Director Feb. 6, 2026 A 6,620 1 0 $1,008
John Neuman Director Feb. 6, 2026 A 12,200 0 0 $0
Kenneth Van Heel Director Feb. 6, 2026 A 7,940 0 0 $0
Allan Collins Director Nov. 13, 2024 A 54,343 0 0 $0
Rick Barnett Director Nov. 13, 2024 A 86,664 0 0 $0
Andres Lobo Director April 12, 2024 A 40,300 0 0 $0
Bruce M. Rodgers Director April 12, 2024 A 44,515 0 0 $0
Richard D. Russell Director April 12, 2024 A 60,300 0 0 $0
Union Carbide Employees' Pension Plan Trust 10% owner Oct. 28, 2022 P 2,966,555 0 0 $0
Dow Employees' Pension Plan Trust 10% owner Oct. 28, 2022 P 4,449,841 0 0 $0
LMFAO Sponsor, LLC 10% owner Oct. 28, 2022 A 2,587,500 0 0 $0
LM FUNDING AMERICA, INC. 10% owner Oct. 28, 2022 A 2,587,500 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 2 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 33,091 SH Aug. 19, 2026 Daily
DFAC · Dimensional ETF Trust 0.00% 2,835 NS July 31, 2026 N-PORT

ICU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 5 analysts BUY
Median target $10.00 +113.2%
1 20.0% Strong Buy
3 60.0% Buy
1 20.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

2 analysts · 2026-10-02

Mean target $10.00 +113.2%

← Below all targets Current price $4.69
Low$8.00 Mean$10.00 High$12.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ICU · · · · · ·
BEAT · · · · · ·
PAVM $6M -1.2 -97.6% 564.8% 2.2% ·
HSCS · · · · · ·
MODD $25M -0.4 · · -260.0% ·
FEMY $34M -1.2 40.8% -812.3% -505.0% ·
SINT $15M -0.6 -64.7% -1018.1% -299.7% 45.3%
ABT $250.18B 33.7 5.7% 14.7% 13.1% ·

Latest News Recent headlines mentioning this company

23
Iran conflict looms large over Takaichi's upcoming summit with Trump, experts say CNBC · 6 months, 2 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed May 13, 2026